Piper Jaffray to Host 30th Annual Healthcare Conference
November 23 2018 - 1:00PM
Business Wire
Piper Jaffray Companies (NYSE: PJC), a leading investment bank
and asset management firm, will host its 30th annual Healthcare
Conference in New York on November 27-29, 2018.
The Piper Jaffray Healthcare Conference will showcase senior
management teams from approximately 300 leading public and private
companies delivering presentations to an audience of more than
2,000 institutional investors, equity portfolio managers and
research analysts. Formerly a two-day event, this year’s three-day
conference will also host more than 2,000 private one-on-one
meetings with company management. Presenting companies represent
several healthcare sectors, including: biotechnology, specialty
pharmaceuticals, medical technology, medical diagnostics, and
healthcare IT & services.
Highlighting the conference will be several panel discussions
featuring industry experts, physicians and academicians moderated
by Piper Jaffray healthcare senior research analysts:
- Migraine Treatment and
PreventionCo-moderated by David Amsellem, Chris Raymond and
Tyler Van Buren
- Hematology Oncology Panel: A
Discussion of the Evolving Hematology Oncology Landscape Ahead of
ASHCo-moderated by Danielle Brill, Pharm.D, Joe Catanzaro, PhD,
Chris Raymond and Tyler Van Buren
- BioPharma M&A Discussion:
Perspectives on Global Trends From Industry LeadersModerated by
Matt Hemsley, MD Healthcare Investment Banking
- The Future of Diabetes Technology
with Company Executives and the FDAModerated by JP McKim,
CFA
“Piper Jaffray has been a longstanding leader in the healthcare
industry. To meet client demand, we added a third day of
presentations and investor meetings this year, which will provide
more opportunities for investors to connect with management from
leading companies in the industry,” said Michael Cox, co-head of
global equities at Piper Jaffray. “Our healthcare conference offers
our clients a distinct and exclusive experience to guide their
investing strategies in 2019 and beyond.”
Follow the conversation using the event hashtag #PJCHCC18
Company and investor participation in the conference is by
invitation only. Clients interested in attending should contact
their Piper Jaffray representative. General and research-related
media inquiries should be directed to
analystmediarelations@pjc.com. All other media inquiries should be
directed to Pamela Steensland at pamela.k.steensland@pjc.com.
Information as of November 23, 2018. Subject to change.
Piper Jaffray Companies (NYSE: PJC) is a leading investment bank
and asset management firm. Securities brokerage and investment
banking services are offered in the U.S. through Piper Jaffray
& Co., member SIPC and FINRA; in Europe through Piper Jaffray
Ltd., authorized and regulated by the U.K. Financial Conduct
Authority; and in Hong Kong through Piper Jaffray Hong Kong
Limited, authorized and regulated by the Securities and Futures
Commission. Asset management products and services are offered
through five separate investment advisory affiliates―U.S.
Securities and Exchange Commission (SEC) registered Advisory
Research, Inc., Piper Jaffray Investment Management LLC, PJC
Capital Partners LLC and Piper Jaffray & Co., and
Guernsey-based Parallel General Partners Limited, authorized and
regulated by the Guernsey Financial Services Commission.
Follow Piper Jaffray: LinkedIn | Facebook | Twitter
© 2018 Piper Jaffray Companies. 800 Nicollet Mall, Suite 1000,
Minneapolis, Minnesota 55402-7036
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181123005231/en/
Pamela SteenslandTel: 612 303-8185pamela.k.steensland@pjc.com
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Piper Jaffray Companies (NYSE:PJC)
Historical Stock Chart
From Sep 2023 to Sep 2024